Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:40 PM
Ignite Modification Date:
2025-12-24 @ 11:40 PM
NCT ID:
NCT02311751
Eligibility Criteria:
Inclusion Criteria Autism Spectrum Disorder (ASD):
* Are fluent in the English language
* Have a diagnosis of high functioning ASD (HF-ASD) (i.e., are verbal with an Intelligence Quotient (IQ) ≥ 70)
* Are competent to consent based on the subjects' ability to provide a spontaneous narrative description of the key elements of the study
* Are clinically stable as determined by their treating physician, with no medication changes over the past 4 weeks
Exclusion Criteria (ASD):
* Have a history of substance abuse or dependence in the last 6 months or have a positive urine toxicology screen
* Have a concomitant major medical or neurologic illness
* Have had a seizure in the past, or have a first-degree relative with epilepsy
* Have an abnormal clinical EEG
* Are pregnant or likely to get pregnant during the next 4 weeks
* Are clinically unstable
* Are on benzodiazepines or anticonvulsant medication
* Have a history of rTMS treatment.
Inclusion Criteria (Healthy Controls):
* Are fluent in the English language
* Competent to consent
Exclusion Criteria (Healthy Controls):
* Have a history of substance abuse or dependence in the last 6 months or have a positive urine toxicology screen
* Have a major medical or neurologic illness
* Have a diagnosed learning disorder or impaired academic or adaptive functioning on history
* Are pregnant
* Have an IQ \< 80
* Have a psychiatric diagnosis on diagnostic interview assessments.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
16 Years
Maximum Age:
35 Years
Study:
NCT02311751
Study Brief:
Protocol Section:
NCT02311751